Management of Residual Mass in Germ Cell Tumors After Chemotherapy

AbstractPurpose of ReviewThe purpose of this review is to educate medical oncologists on the management of patients with residual germ cell tumors and the role of surgical resection after platinum-based chemotherapy.Recent FindingsPatients with non-seminomatous testicular cancer and residual enlarged retroperitoneal lymph nodes>  1 cm following induction chemotherapy with normal tumor markers should undergo a post-chemotherapy retroperitoneal lymph node dissection. All patients with primary mediastinal non-seminoma should undergo surgical resection of the mediastinal mass post-chemotherapy. These are complex surgeries an d require expert surgeons in high-volume centers. Patients with advanced testicular seminoma who have residual masses less than 3 cm after chemotherapy can be observed without further intervention. Patients with a residual mass>  3 cm should be evaluated with PET scan after 6 weeks of chemotherapy. Residual mass with negative PET scan can be followed by surveillance while a positive PET scan requires further work up to rule out active disease.

Source: Current Oncology Reports - January 21, 2019 Category: Cancer & Oncology Source Type: research